Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to examine the efficacy of a 12-week smell training intervention for participants with olfactory dysfunction following an infection of the upper respiratory tract.


Clinical Trial Description

Olfactory dysfunction affects up to fifteen percent of the general population and can cause significant psychosocial distress including decreased appetite, reduced self-hygiene, and mood disturbances. This study aims to study the efficacy of smell training for patients with olfactory dysfunction following a viral upper respiratory tract infection. Eligible participants will complete a 30-day course of budesonide nasal saline irrigation. Participants who do not show improvement in their olfaction based on composite smell and taste tests will be eligible to receive a baseline resting-state fMRI (rs-fMRI) and complete a 12-week smell training intervention program. Smell training involves participants smelling 4 odors (phenyl ethyl alcohol, eucalyptus, lemon, and eugenol) twice a day for 12 weeks. Following completion of smell training, participants will undergo repeat smell and taste tests as well as rs-fMRI to ascertain the efficacy of smell training. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02985515
Study type Interventional
Source Washington University School of Medicine
Contact
Status Completed
Phase N/A
Start date September 28, 2016
Completion date November 20, 2019

See also
  Status Clinical Trial Phase
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Recruiting NCT06066307 - Olfactory Performance in Culinary Arts Students Phase 4
Completed NCT05445921 - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Phase 1/Phase 2
Recruiting NCT05855369 - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss Phase 2/Phase 3
Recruiting NCT03574701 - Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL N/A
Enrolling by invitation NCT04764981 - Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) N/A
Completed NCT03990766 - Smell Changes & Efficacy of Nasal Theophylline Phase 2
Withdrawn NCT05542095 - Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia Phase 1
Recruiting NCT04791436 - Oral and Olfactory Complications of Recovered COVID-19 Patients
Enrolling by invitation NCT05038475 - Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
Completed NCT01332825 - cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose N/A
Completed NCT04789499 - Smell in Covid-19 and Efficacy of Nasal Theophylline Phase 2
Active, not recruiting NCT04761458 - Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality N/A
Completed NCT04406584 - Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction N/A
Completed NCT03611673 - At-Home Olfactory Training N/A
Completed NCT04700891 - Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality N/A
Recruiting NCT04466982 - Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
Recruiting NCT04869436 - Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis Phase 4
Recruiting NCT05448898 - The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction N/A
Completed NCT04235153 - CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients